Takip et
HALUK YUZUGULLU
HALUK YUZUGULLU
Astrazeneca Pharmaceuticals
astrazeneca.com üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting
HYJJZ Lauren M. Thorpe
Nature Reviews Cancer 15 (1), 7–24, 2014
1349*2014
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors
JJZ Shom Goel, Qi Wang, April C. Watt, Sara M. Tolaney, Deborah A. Dillon ...
Cancer Cell 29 (3), p255–269, 2016
4232016
CDK7-dependent transcriptional addiction in triple-negative breast cancer
Y Wang, T Zhang, N Kwiatkowski, BJ Abraham, TI Lee, S Xie, H Yuzugullu, ...
Cell 163 (1), 174-186, 2015
4132015
Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells
H Yuzugullu, K Benhaj, N Ozturk, S Senturk, E Celik, A Toylu, N Tasdemir, ...
Molecular cancer 8, 1-20, 2009
3032009
Senescence and immortality in hepatocellular carcinoma
M Ozturk, A Arslan-Ergul, S Bagislar, S Senturk, H Yuzugullu
Cancer letters 286 (1), 103-113, 2009
1202009
Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers.
SP Hydbring P, Wang Y, Fassl A, Li X, Matia V, Otto T, Choi YJ, Sweeney KE ...
Cancer Cell 31 (4), 576–590, 2017
952017
Aflatoxin genotoxicity is associated with a defective DNA damage response bypassing p53 activation
O Gursoy‐Yuzugullu, H Yuzugullu, M Yilmaz, M Ozturk
Liver International 31 (4), 561-571, 2011
922011
Genome-wide transcriptional reorganization associated with senescence-to-immortality switch during human hepatocellular carcinogenesis
G Yildiz, A Arslan-Ergul, S Bagislar, O Konu, H Yuzugullu, ...
PloS one 8 (5), e64016, 2013
682013
Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110α
K Gritsman, H Yuzugullu, T Von, H Yan, L Clayton, C Fritsch, SM Maira, ...
The Journal of clinical investigation 124 (4), 1794-1809, 2014
652014
A PI3K p110β–Rac signalling loop mediates Pten-loss-induced perturbation of haematopoiesis and leukaemogenesis
H Yuzugullu, L Baitsch, T Von, A Steiner, H Tong, J Ni, LK Clayton, ...
Nature communications 6 (1), 8501, 2015
462015
The ability to generate senescent progeny as a mechanism underlying breast cancer cell heterogeneity
M Mumcuoglu, S Bagislar, H Yuzugullu, H Alotaibi, S Senturk, ...
PloS one 5 (6), e11288, 2010
272010
NTRK2 activation cooperates with PTEN deficiency in T-ALL through activation of both the PI3K–AKT and JAK–STAT3 pathways
H Yuzugullu, T Von, LM Thorpe, SR Walker, TM Roberts, DA Frank, ...
Cell discovery 2 (1), 1-13, 2016
212016
Evaluation of ATAD2 as a Potential Target in Hepatocellular Carcinoma
U Ekin, H Yuzugullu, C Ozen, P Korhan, E Bagirsakci, F Yilmaz, ...
Journal of Gastrointestinal Cancer, 1-14, 2021
22021
Development of a second-generation TRAIL agonist and predictive biomarker profile for colorectal cancer
S Ghassemifar, Y Hashambhoy-Ramsay, H Yuzugullu, T Utermark, ...
Cancer Research 79 (13), 2019
2019
Methods for selecting and treating patients with a trail-based therapeutic or death receptor agonist
D Tamara, S Ghassemifar, Y Hashambhoy-ramsay, DHC MARCANTONIO, ...
US Patent App. 16/305,289, 2019
2019
INVESTIGATION OF CAUSATIVE AGENTS IN COMMUNITY-ACQUIRED ATYPICAL PNEUMONIA CASES
E ÇALIŞKAN, Ş ÖKSÜZ, C ÖZTÜRK, I Sahin, O Kilincel, N Akar, ...
FRESENIUS ENVIRONMENTAL BULLETIN 28 (5), 2019
2019
MM-161, a first-in-class pan-FGFR antibody
T Dake, G Finn, M Geddie, N Kohli, M Razlog, L Xu, V Paragas, ...
Cancer Research 77 (13_Supplement), 22-22, 2017
2017
Targeted Therapy for Hepatocellular Carcinoma: What`s New?
H Yuzugullu, O Gursoy-Yuzugullu
Liver Res Open J 1 (1), e1-e3, 2015
2015
PI3K-p110β is required for leukemic transformation and HSC depletion in the absence of Pten
H Yuzugullu, L Baitsch, A Steiner, LK Clayton, K Gritsman, JJ Zhao
Cancer Research 74 (19_Supplement), 4775-4775, 2014
2014
Doxorubicin-induced senescence in hepatocellular carcinoma cells
O Gursoy-Yuzugullu, H Yuzugullu, M Ozturk
Cancer Research 70 (8_Supplement), 3220-3220, 2010
2010
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20